EV/EBITDA:
-4.67-0.13(-2.86%)Summary
- As of today (May 29, 2025), NAMS EV/EBITDA is -4.67, with a fall of -0.13 (-2.86%) during the most recent trading session on May 28, 2025.
- Over the past year, NAMS EV/EBITDA has increased by +1.69 (+26.57%).
- NAMS EV/EBITDA is now -42.38% below its all-time high of -3.28.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.9% | +2.9% | +1.8% |
| 1 m1 month | +10.4% | -10.3% | -6.7% |
| 3 m3 months | +31.7% | -27.6% | -17.6% |
| 6 m6 months | +41.5% | -17.1% | -12.8% |
| ytdytd | +43.8% | -40.4% | -32.6% |
| 1 y1 year | +26.6% | -2.6% | -8.8% |
| 5 y5 years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.54 | -2.9% | -5.96 | +21.6% |
| 3 m | 3-month | -3.61 | -29.4% | -8.05 | +42.0% |
| 6 m | 6-month | -3.61 | -29.4% | -13.39 | +65.1% |
| 1 y | 1-year | -3.61 | -29.4% | -13.39 | +65.1% |
| 3 y | 3-year | -3.28 | -42.4% | -13.39 | +65.1% |
| 5 y | 5-year | -3.28 | -42.4% | -13.39 | +65.1% |
| alltime | all time | -3.28 | -42.4% | -13.39 | +65.1% |
NAMS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -4.67(-43.8%) |
| Date | Value |
|---|---|
| 2024 | -8.31(+153.4%) |
| 2023 | -3.28 |
FAQ
- What is NewAmsterdam Pharma Company NV EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company NV EV/EBITDA?
The current EV/EBITDA of NAMS is -4.67
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high EV/EBITDA is -3.28
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company NV EV/EBITDA has changed by +3.64 (+43.80%) since the beginning of the year
What is NewAmsterdam Pharma Company NV EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by +1.69 (+26.57%)